Impact of Dhatri Avaleha administration in third trimester on neonatal Apgar score and Immunity

Background: Ayurveda provides a comprehensive approach to antenatal care, emphasizing the nourishment and protection of both mother and fetus during pregnancy. Dhatri Avaleha, a traditional polyherbal formulation centered on Amalaki (Emblica officinalis), is widely revered for its Rasayana, Ojovardhaka, and Balya properties. Administered during the third trimester, it is traditionally believed to improve maternal strength, facilitate normal delivery, and enhance neonatal outcomes. Objective: This study investigates the effect of Dhatri Avaleha administered in the third trimester of pregnancy on neonatal Apgar scores and markers of immune competence, interpreted through both classical Ayurvedic principles and modern biomedical evaluation. Methods: A cohort of 60 healthy pregnant women was observed in a controlled clinical setting. The study group received Dhatri Avaleha during the final trimester, while the control group received standard antenatal care. Outcome measures included Apgar scores at 1 and 5 minutes after birth, cord blood immunoglobulin levels, and lymphocyte counts. Maternal hemoglobin and serum antioxidant levels were also measured pre- and post-intervention. Results: Significant improvements were observed in maternal hemoglobin levels and neonatal Apgar scores in the intervention group. Immunological markers indicated enhanced neonatal immune function. Classical Ayurvedic interpretations of fetal Ojas development, and maternal Rasa Dhatu enrichment were used to support the findings. Conclusion: Administration of Dhatri Avaleha in the third trimester appears to positively impact neonatal vitality and immunity. The study reaffirms the relevance of Ayurvedic Rasayana therapy in contemporary obstetric practice and highlights the potential of integrative prenatal care strategies